Australian Prescriber Podcast cover art

Australian Prescriber Podcast

Australian Prescriber Podcast

By: Australian Prescriber
Listen for free

About this listen

The Australian Prescriber Podcast provides a regular dive into some of the many great articles that Australian Prescriber publishes every two months. In each episode, our host will chat with one of the authors from a recent issue of Australian Prescriber.https://www.tg.org.au/copyright-permission/ Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • E211 - Preventing infections in immunosuppressed patients
    Mar 30 2026

    Dhineli Perera speaks to infectious diseases physicians Aadith Ashok and Bradley Gardiner about their paper on preventing infections in immunosuppressed patients. They explain how to individualise risk assessments and screening investigations, and discuss antimicrobial prophylaxis and helpful safe living advice for patients. Read the full article in Australian Prescriber.

    Show More Show Less
    24 mins
  • E210 - Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis – is it effective?
    Mar 16 2026

    David Liew talks to rheumatologist Jessica Pisaniello about her paper on Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis. They discuss the limited benefits and the risks of using of hyaluronic acid in joints, what current guidelines recommend, and what the evidence says. Jessica also advises on how to approach conversations with patients who ask prescribers about using hyaluronic acid. Read the full article in Australian Prescriber.

    Show More Show Less
    19 mins
  • E209 - Secondary prevention of acute coronary syndromes: a summary of the new 2025 Australian guideline
    Mar 2 2026

    Laura Beaton chats with David Brieger, head of cardiology at Concord Hospital, Sydney, about the 2025 Australian acute coronary syndromes [ACS] clinical guideline. David explains the importance of secondary prevention for ACS, including new approaches to tailoring the duration of dual antiplatelet therapies, new lipid targets, and the limited role of beta blockers and colchicine. Read the full article in Australian Prescriber.

    Show More Show Less
    24 mins
No reviews yet